• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    AVEO Pharmaceuticals, Inc. (AVEO)

    -NasdaqGS
    1.84 Up 0.12(6.98%) Apr 17, 4:00PM EDT
    |After Hours : 1.91 Up 0.07 (3.80%) Apr 17, 7:55PM EDT
    Add to Portfolio
    Prev Close:1.72
    Open:1.76
    Bid:1.88 x 300
    Ask:1.91 x 1000
    1y Target Est:3.00
    Beta:1.03
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:1.74 - 1.97
    52wk Range:0.61 - 2.02
    Volume:3,302,160
    Avg Vol (3m):1,187,640
    Market Cap:95.33M
    P/E (ttm):N/A
    EPS (ttm):-1.01
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    AVEOUp 6.98%95.33M
    AMGNDown 1.97%124.13B
    PFEDown 0.43%214.76B
    RHHBYDown 1.53%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.92
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.77
    Quarterly EPS Est (Mar-15) :-0.25
    Mean Recommendation*:3.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted therapies for patients with cancer and related diseases. Its product candidates under development include Tivozanib, an tyrosine kinase inhibitor for various vascular endot... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback